Comparative PK [Study Per­for­mance]

posted by PVRC – India, 2021-05-10 20:12 (1078 d 16:56 ago) – Posting: # 22338
Views: 2,420

Hi all,

For one of the product, the agency recommend to demonstrate comparative PK in the absence of bioequivalence. The question is that whether all bioequivalence criteria (like 80-125%, group effect etc.,) are still applicable to demonstrate comparative PK.

Thanks in advance....

Complete thread:

UA Flag
Activity
 Admin contact
22,990 posts in 4,826 threads, 1,666 registered users;
51 visitors (1 registered, 50 guests [including 4 identified bots]).
Forum time: 13:09 CEST (Europe/Vienna)

If you don’t like something change it;
if you can’t change it, change the way you think about it.    Mary Engelbreit

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5